Arming Immune Cells for Battle: A Brief Journey through the Advancements of T and NK Cell Immunotherapy
Philipp Wendel(Goethe University Frankfurt), Evelyn Ullrich(Goethe University Frankfurt), Nawid Albinger(Goethe University Frankfurt), Leander Künnemeyer(Goethe University Frankfurt), Tobias Bopp(Johannes Gutenberg University Mainz), Eva Rettinger(Goethe University Frankfurt), Tobias Bexte(Goethe University Frankfurt), Vinzenz Särchen(Goethe University Frankfurt), Andréas Mackensen(University Medical Center Freiburg), Lisa Marie Reindl(Goethe University Frankfurt)
Cited by 46
Related Papers
Interferon-Regulatory Factor 4 Is Essential for the Developmental Program of T Helper 9 Cells
|Immunity|2010|539
Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy
|Cell Reports|2019|297
Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells
|Cancer Immunology Immunotherapy|2000|240
Advancements and challenges in CAR T cell therapy in autoimmune diseases
|Nature Reviews Rheumatology|2024|203
CD19-CAR T-cell therapy induces deep tissue depletion of B cells
|Annals of the Rheumatic Diseases|2024|150